Literature DB >> 18650025

Cognitive impairment correlates to low auditory event-related potential amplitudes in type 1 diabetes.

Gerald K Cooray1, Liselotte Maurex, Tom Brismar.   

Abstract

Type 1 diabetes may be associated with a mild decline in cognitive function and mostly in mental speed. In order to study the pathophysiology of this, we have investigated auditory event-related potentials (AERP) and their relation to cognitive function in diabetes patients. AERP was recorded in patients with type 1 diabetes (n=119) and in a healthy control group (n=61). AERP was obtained with an odd-ball and a two-stimulus paradigm. Cognitive function was evaluated in 10 domains in the patients. Patients had normal N100 latency, but a highly significant decrease in auditory N100 amplitude (p<10(-6)), which correlated with a decrease in psychomotor speed but not with function in other domains. Psychomotor speed also correlated with P300 amplitude, although P300 amplitude was only slightly decreased in the patients. Even stronger correlations were found with the parietal N100-P300 peak-to-peak amplitude, which correlated both to psychomotor speed (rho=0.61, p<10(-7)) and processing speed (p<0.005). P300 latency was increased in patients, and this correlated to low global cognitive score and older age. We conclude that the decline in psychomotor speed in type 1 diabetes is associated with a highly significant decrease in the auditory N100 peak amplitude. This association and the relatively small abnormality in P300 latency is quite different from those generally found in dementia, and suggest that the underlying defect is located in the brain stem or the white matter. Presumably small conduction defects in ascending fibers can distort the firing synchrony necessary for signal generation in the cortex.

Entities:  

Mesh:

Year:  2008        PMID: 18650025     DOI: 10.1016/j.psyneuen.2008.04.013

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  4 in total

1.  DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress.

Authors:  Bei-Ni Wang; Cheng-Biao Wu; Zi-Miao Chen; Pei-Pei Zheng; Ya-Qian Liu; Jun Xiong; Jing-Yu Xu; Pei-Feng Li; Abdullah Al Mamun; Li-Bing Ye; Zhi-Long Zheng; Yan-Qing Wu; Jian Xiao; Jian Wang
Journal:  Acta Pharmacol Sin       Date:  2021-01-18       Impact factor: 6.150

2.  Amelioration of Auditory Response by DA9801 in Diabetic Mouse.

Authors:  Yeong Ro Lee; Bin Na Hong; You Ri Her; Rodrigo Castañeda; Hyo Won Moon; Tong Ho Kang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-24       Impact factor: 2.629

3.  A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder.

Authors:  Anusha Baskaran; Roumen Milev; Roger S McIntyre
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-17       Impact factor: 2.570

4.  Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.

Authors:  Juan José Ramos-Rodriguez; Carmen Infante-Garcia; Lucia Galindo-Gonzalez; Yaiza Garcia-Molina; Alfonso Lechuga-Sancho; Mónica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2015-07-09       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.